Microbiology Culture Market to Hit $40.20B by 2033 at 7.2% CAGR | Forecast by DataM Intelligence

June 05, 2025 10:45 PM AEST | By EIN Presswire
 Microbiology Culture Market to Hit $40.20B by 2033 at 7.2% CAGR | Forecast by DataM Intelligence
Image source: EIN Presswire
AUSTIN, TX, UNITED STATES, June 5, 2025 /EINPresswire.com/ -- Microbiology Culture Market Outlook 2025

The Microbiology Culture Market Size 2025 was valued at USD 20.38 billion in 2024 and is anticipated to grow to USD 40.20 billion by 2033, experiencing a compound annual growth rate.

To Download Sample Report: https://www.datamintelligence.com/download-sample/microbiology-culture-market

Key Developments:

In November 2024, Dedalus Group and Ibex Medical Analytics introduced a fully integrated, AI-powered digital pathology solution for cancer diagnosis across key European markets. This collaboration merges Ibex’s Galen™ platform with Dedalus’ Digital Pathology system, advancing the digitization of anatomic pathology labs.

In September 2024, Roche enhanced its digital pathology platform by adding over 20 AI algorithms from eight new partners, strengthening support for pathologists and researchers in cancer diagnostics through cutting-edge AI tools.

Regional Outlook

North America

North America continues to be a leading region in the microbiology culture market. With its robust healthcare infrastructure, continuous innovation, and a high level of research activity, the region provides a fertile environment for market expansion. Pharmaceutical companies, food manufacturers, and government laboratories frequently use culture-based tests for regulatory compliance and product development.

Europe

Europe shows consistent demand for microbiology cultures, largely driven by environmental monitoring, public health screening, and food safety programs. Regulatory frameworks in the region promote regular microbiological testing across industries, encouraging laboratories to use advanced culture media and techniques.

Asia-Pacific

The Asia-Pacific region is witnessing rapid growth. Increased awareness about disease prevention, improving healthcare access, and expanding pharmaceutical manufacturing are pushing the microbiology culture market forward in countries like India, China, and Japan. Moreover, the region is seeing growing interest in clinical diagnostics and academic research.

Key Players in the Market

BD

Merck KGaA

Thermo Fisher Scientific Inc.

Sartorius AG

Eiken Chemical co. Lti.

HiMedia Laboratories Pvt. Ltd

Kerry Group Plc

BioMérieux S.A.

Mettler Toledo

Yokogawa Electric Corporation

Conda Laboratories S.A

SATAKE MultiMix Corporation

B.E. MARUBISHI CO., LTD.

ABLE Corporation & Biott Corporation

Market Segmentation:

By Product Type: Culture Equipment, Bioreactors, Bioreactor Devices, Measuring Instruments, PH Sensors, Dissolved Oxygen Sensors, Temperature Sensors, Others, Analytical Devices, Cell Counters, Spectrometers, Others, Sterilization Equipment, Incubators, Others, Culture Supplements, Measuring Instruments, PH Sensors, Temperature Sensors, Dissolved Oxygen Sensors, Others, Culture Instruments, Petri Dishes, Loops & Needles, Micropipettes, Centrifuge, Others, Analytical Devices, Cell Counters, Spectrometers, Others

By Culture Type: Eukaryotic Culture, Bacterial Culture, , By Consistency, Liquid Media, Solid Culture Media, Semi-solid Media

By Application: Pharmaceuticals, Food & Beverage Industry, Others, Water Testing, Cosmetics

Latest News: USA

In the United States, the microbiology culture market is witnessing robust growth due to increasing health awareness and the demand for advanced testing systems in both clinical and industrial settings. In recent months, several labs and biotech firms have expanded their capacity to produce high-grade culture media in response to rising demand from pharmaceutical companies.

Hospitals are also adopting new point-of-care microbial testing devices that use improved culture methods to identify bacteria and fungi within hours, not days. This has enhanced patient management, particularly in emergency departments and ICUs.

Furthermore, several academic medical centers are now integrating microbiology culture-based diagnostics into broader genomic research, contributing to a better understanding of antimicrobial resistance and infectious disease dynamics.

Latest News: Japan

Japan’s microbiology culture market continues to expand steadily, driven by government initiatives to improve public health and ensure food safety. Over the past year, several food and beverage companies in Japan have strengthened their quality control protocols using advanced microbial culture techniques.

Japanese pharmaceutical firms are also investing heavily in microbial fermentation processes for drug development, particularly for biologics and probiotics. Additionally, the country’s industrial microbiology segment is seeing increased demand for microbial testing in manufacturing environments, including cosmetic, dairy, and beverage industries.

Universities and research institutions in Japan are collaborating more closely with diagnostic firms to develop faster, more efficient culture-based solutions for emerging pathogens. This aligns with the country’s broader public health goals of early outbreak detection and infection control.

Conclusion

The microbiology culture market is on a strong growth path, fueled by the pressing need for accurate diagnostics, quality control, and pharmaceutical innovation. With technological advancements improving efficiency, regions like North America and Asia-Pacific are expected to lead in both adoption and development.

In the coming years, culture-based diagnostics will remain indispensable, especially as the world grapples with antimicrobial resistance, emerging infections, and the need for sustainable food safety practices. The market’s evolution reflects a commitment to scientific progress, better healthcare outcomes, and global health security.

Here are the Latest Related Reports By DataM Intelligence Expert’s

Immunoprotein Diagnostic Testing Market Size

Difficult-to-Express Proteins Market Size

Sai Kiran
DataM Intelligence 4Market Research
+1 877-441-4866
[email protected]
Visit us on social media:
LinkedIn
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.